Antipneumococcal and Antistaphylococcal Activities of Ranbezolid (RBX 7644), a New Oxazolidinone, Compared to Those of Other Agents
AUTOR(ES)
Hoellman, Dianne B.
FONTE
American Society for Microbiology
RESUMO
For 260 pneumococcal and 266 staphylococcal strains, ranbezolid MICs ranged from ≤0.06 to 4 μg/ml. The MICs for pneumococci were similar irrespective of the strains' β-lactam, macrolide, or quinolone susceptibilities, and ranbezolid MICs for coagulase-negative staphylococci were lower than those for Staphylococcus aureus. Ranbezolid was bacteriostatic against pneumococci. Ranbezolid MICs were similar to or lower than those of linezolid. Vancomycin and quinupristin-dalfopristin were also very active.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=149337Documentos Relacionados
- Antianaerobe Activity of RBX 7644 (Ranbezolid), a New Oxazolidinone, Compared with Those of Eight Other Agents
- Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents
- Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant Pneumococci
- Antipneumococcal Activity of BMS 284756 Compared to Those of Six Other Agents
- Antipneumococcal Activity of Ertapenem (MK-0826) Compared to Those of Other Agents
